106 related articles for article (PubMed ID: 12393027)
1. Immunohistochemical detection of hepatic GM1 and GM2 gangliosides in streptozotocin-induced diabetic rats.
Abregú AV; Genta SB; Sánchez Riera AN; Sánchez SS
Hepatol Res; 2002 Nov; 24(3):256. PubMed ID: 12393027
[TBL] [Abstract][Full Text] [Related]
2. Changes in liver gangliosides in streptozotocin-induced diabetic rats.
Sánchez SS; Abregú AV; Aybar MJ; Sánchez Riera AN
Cell Biol Int; 2000; 24(12):897-904. PubMed ID: 11114239
[TBL] [Abstract][Full Text] [Related]
3. Renal gangliosides are involved in lead intoxication.
Aguilar RP; Genta S; Sánchez S
J Appl Toxicol; 2008 Mar; 28(2):122-31. PubMed ID: 17503479
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of gangliosides in the ovary and uterus of streptozotocin-induced and db/db diabetic mice.
Kim SM; Kwak DH; Kim SM; Jung JU; Lee DH; Lee S; Jung KY; Do SI; Choo YK
Arch Pharm Res; 2006 Aug; 29(8):666-76. PubMed ID: 16964762
[TBL] [Abstract][Full Text] [Related]
5. Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides.
Kotani M; Ozawa H; Kawashima I; Ando S; Tai T
Biochim Biophys Acta; 1992 Jul; 1117(1):97-103. PubMed ID: 1627599
[TBL] [Abstract][Full Text] [Related]
6. Precursor-product relationship between GM1 and GD1a biosynthesized from exogenous GM2 ganglioside in rat liver.
Trinchera M; Ghidoni R
J Biochem; 1990 Apr; 107(4):619-23. PubMed ID: 2358435
[TBL] [Abstract][Full Text] [Related]
7. Evidence for sialidase hydrolyzing gangliosides GM2 and GM1 in rat liver plasma membrane.
Miyagi T; Tsuiki S
FEBS Lett; 1986 Oct; 206(2):223-8. PubMed ID: 3758350
[TBL] [Abstract][Full Text] [Related]
8. Establishment of monoclonal antibodies specific for ganglioside GM1: detection of ganglioside GM1 in small cell lung carcinoma cell lines and tissues.
Watarai S; Kiura K; Shigeto R; Shibayama T; Kimura I; Yasuda T
J Biochem; 1994 Nov; 116(5):948-54. PubMed ID: 7896755
[TBL] [Abstract][Full Text] [Related]
9. Rat pancreatic ganglioside expression: differences between a model of autoimmune islet B cell destruction and a normal strain.
Dotta F; Tiberti C; Previti M; Anastasi E; Andreani D; Lenti L; Pontieri GM; Gianani R; Appel MC; Eisenbarth GS
Clin Immunol Immunopathol; 1993 Feb; 66(2):143-9. PubMed ID: 8453786
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic islet ganglioside expression in nonobese diabetic mice: comparison with C57BL/10 mice and changes after autoimmune beta-cell destruction.
Dotta F; Peterson LB; Previti M; Metzger J; Tiberti C; Anastasi E; Zoppitelli P; Wicker LS; Di Mario U
Endocrinology; 1992 Jan; 130(1):37-42. PubMed ID: 1727711
[TBL] [Abstract][Full Text] [Related]
11. Increased concentration of GM1-ganglioside in cerebrospinal fluid in dogs with GM1- and GM2-gangliosidoses and its clinical application for diagnosis.
Satoh H; Yamato O; Asano T; Yamasaki M; Maede Y
J Vet Diagn Invest; 2004 May; 16(3):223-6. PubMed ID: 15152837
[TBL] [Abstract][Full Text] [Related]
12. Gangliosides and autoimmune diabetes.
Misasi R; Dionisi S; Farilla L; Carabba B; Lenti L; Di Mario U; Dotta F
Diabetes Metab Rev; 1997 Sep; 13(3):163-79. PubMed ID: 9307889
[TBL] [Abstract][Full Text] [Related]
13. Gangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by different mechanisms.
Sachinidis A; Kraus R; Seul C; Meyer zu Brickwedde MK; Schulte K; Ko Y; Hoppe J; Vetter H
Eur J Cell Biol; 1996 Sep; 71(1):79-88. PubMed ID: 8884181
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of ganglioside and asialoglycosphingolipid antigens in adult T-cell leukemia cells.
Suzuki Y; Hirabayashi Y; Matsumoto N; Kato H; Hidari K; Tsuchiya K; Matsumoto M; Hoshino H; Tozawa H; Miwa M
Jpn J Cancer Res; 1987 Oct; 78(10):1112-20. PubMed ID: 2890614
[TBL] [Abstract][Full Text] [Related]
15. Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects.
Sonderfeld S; Conzelmann E; Schwarzmann G; Burg J; Hinrichs U; Sandhoff K
Eur J Biochem; 1985 Jun; 149(2):247-55. PubMed ID: 3922757
[TBL] [Abstract][Full Text] [Related]
16. Gangliosides of rat eye lens: a severe reduction in the content of C-series gangliosides following streptozotocin treatment.
Saito M; Sugiyama K
Life Sci; 2000 Sep; 67(15):1891-9. PubMed ID: 11043611
[TBL] [Abstract][Full Text] [Related]
17. Gangliosides GM1 and GM2 induce vascular smooth muscle cell proliferation via extracellular signal-regulated kinase 1/2 pathway.
Gouni-Berthold I; Seul C; Ko Y; Hescheler J; Sachinidis A
Hypertension; 2001 Nov; 38(5):1030-7. PubMed ID: 11711493
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of glycosylation and deglycosylation of exogenously administered ganglioside GM1 in mouse liver.
Ghidoni R; Sonnino S; Chigorno V; Venerando B; Tettamanti G
Biochem J; 1983 Aug; 213(2):321-9. PubMed ID: 6615438
[TBL] [Abstract][Full Text] [Related]
19. Ganglioside expression in human pancreatic islets.
Dotta F; Colman PG; Lombardi D; Scharp DW; Andreani D; Pontieri GM; Di Mario U; Lenti L; Eisenbarth GS; Nayak RC
Diabetes; 1989 Nov; 38(11):1478-83. PubMed ID: 2695376
[TBL] [Abstract][Full Text] [Related]
20. Gangliosides in rat kidney: composition, distribution, and developmental changes.
Saito M; Sugiyama K
Arch Biochem Biophys; 2001 Feb; 386(1):11-6. PubMed ID: 11360994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
